Founded in 2017, Shanghai Sinovent Biopharmaceutical Co., Ltd. is a biopharmaceutical enterprise that integrates scientific research prowess with commercialization expertise to form a platform-based model for novel drug development. Harnessing proprietary advancements in targeted therapies, anti-infectives, and PROTAC technology platforms, Xinovi has established an innovative pipeline of drug candidates, including BLI inhibitors, EZH2 inhibitors, hURAT1 inhibitors, and next-generation Antibody-Drug Conjugates (ADCs). These developments target a spectrum of therapeutic areas, including oncology, infectious diseases, and metabolic disorders.

Disease Domain	Count

Neoplasms	2
Endocrinology and Metabolic Disease	1

Top 5 Drug Type	Count

Antibody drug conjugate (ADC)	2

Top 5 Target	Count

CLDN18.2(Claudin 18.2)	1
tissue factor	1

Corporation Tree

Boost your research with our corporation tree data.

view full example data

Pipeline

Pipeline Snapshot as of 25 Dec 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Phase 1

Phase 2

Current Projects

Drug(Targets)	Indications	Global Highest Phase

XNW-28012 ( tissue factor )	Advanced Malignant Solid Neoplasm More	Phase 1/2
XNW-27011 ( CLDN18.2 )	Solid tumor More	Phase 1

Deal

Boost your decision using our deal data.

view full example data

Translational Medicine

Boost your research with our translational medicine data.

view full example data

Profit

Explore the financial positions of over 360K organizations with Synapse.

view full example data

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.

view full example data

Investment

Gain insights on the latest company investments from start-ups to established corporations.

view full example data

Financing

Unearth financing trends to validate and advance investment opportunities.

view full example data

Chat with Hiro

Get started for free today!

Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.

Start your data trial now!

Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.

Bio

Bio Sequences Search & Analysis

Chemical

Chemical Structures Search & Analysis